Centrum Medyczne ENEL-MED (WAR:ENE) Growth Rank: 7 (As of Sep. 21, 2026) — 30% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:ENE Centrum Medyczne ENEL-MED SA WAR:ENE
80 GF Score
Price zł20.20
GF Value zł27.75
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED Growth Rank?

Centrum Medyczne ENEL-MED WAR:ENE 80 Growth Rank is 7 as of Sep. 21, 2026, which is 30% below its 10-year median of 10.00. GuruFocus rates WAR:ENE with a GF Score™ of 80/100 and a GF Value™ of zł27.75 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Centrum Medyczne ENEL-MED has the Growth Rank of 7.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Centrum Medyczne ENEL-MED Growth Rank Related Terms

WAR:ENE vs HCA, THC, EHC: Growth Rank Comparison

For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Centrum Medyczne ENEL-MED Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's Growth Rank distribution charts can be found below:

* The bar in red indicates where Centrum Medyczne ENEL-MED's Growth Rank falls into.


WAR:ENE
80GF Score
Centrum Medyczne ENEL-MED SA WAR:ENE
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 7 mean?
Centrum Medyczne ENEL-MED (WAR:ENE) has a Growth Rank of 7 as of Sep. 21, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Centrum Medyczne ENEL-MED and its competitors. This is 30% below median its historical median of 10.00. Over the past decade, Centrum Medyczne ENEL-MED's Growth Rank has ranged from 5.00 to 10.00.
Is Centrum Medyczne ENEL-MED's Growth Rank too high?
Centrum Medyczne ENEL-MED's current Growth Rank of 7 is 30% below median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 10.00. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's Growth Rank compare to HCA and THC?
Centrum Medyczne ENEL-MED's Growth Rank of 7 can be compared against companies in the Healthcare Providers & Services industry. Historically, Centrum Medyczne ENEL-MED's own Growth Rank has ranged from 5.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Centrum Medyczne ENEL-MED and its competitors. Centrum Medyczne ENEL-MED's current Growth Rank is 7, which is 30% below median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł27.75, compared to a current price of zł20.20 — trading 27.2% below its estimated fair value. The current Growth Rank is 7, which is 30% below median its 10-year median of 10.00. Centrum Medyczne ENEL-MED's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current Growth Rank is 7 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of zł20.20 is trading 27.2% below its estimated GF Value™ of zł27.75. GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.

Key valuation signals for WAR:ENE:

  • Growth Rank: 7 (30% below median its 10-year median of 10.00)
  • GF Value™: zł27.75 vs. price of zł20.20 (27.2% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Centrum Medyczne ENEL-MED Business Description

Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
80GF Score

Get the complete analysis for WAR:ENE

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł20.20
Price
zł27.75
GF Value